Overview
Dr. Wendy O’Meara is a Professor of Medicine and Global Health at Duke University, a visiting professor at Moi University, and the Deputy Director of the Duke Global Health Institute. She divides her time between the US and Kenya.
Dr. O’Meara has dedicated the last 20 years to community-based approaches for malaria treatment and prevention in East Africa. Her team’s work focuses on expanding access to accurate diagnosis and treatment, mapping silent reservoirs of transmission using parasite genetic signatures, and tackling emerging threats to malaria control in vulnerable populations. She serves on the Strategic Advisory Group of Experts for the Africa CDC and is an advocate for data justice and equitable data governance in global research.
Dr. O’Meara completed her PhD in Chemical Engineering at MIT. She then joined Fogarty International Center at the NIH to apply her quantitative and modeling skills to vector borne diseases. Her collaboration with KEMRI-Wellcome Trust using hospital surveillance data to understand malaria transmission led her to Kenya in 2007. The collaborative research program built with colleagues at Moi University is based in Eldoret, Kenya with hubs in western and northern Kenya. The team works closely with county health teams and frequently advises the Division of National Malaria Control.
Current Appointments & Affiliations
Recent Publications
Do Piperonyl Butoxide Long-Lasting Insecticide Treated Nets Provide Additional Protection Against Malaria Infections Compared with Conventional Nets in an Operational Setting in Western Kenya?
Journal Article Am J Trop Med Hyg · November 18, 2025 Malaria control in sub-Saharan Africa has stagnated despite widespread adoption of control measures such as long-lasting insecticidal nets (LLINs). Progress has stalled, in part, because of pyrethroid insecticide resistance, driving the need for retooling ... Full text Link to item CiteIncidence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in a Rural Community in Western Kenya during the First 24 Months of the Coronavirus Disease 2019 Pandemic.
Journal Article Am J Trop Med Hyg · November 5, 2025 Seroreactivity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens was commonly reported in African settings during the early stages of the coronavirus disease 2019 pandemic. Severe acute respiratory syndrome coronavirus 2 neutralizing ... Full text Link to item CiteClimate change, development, and resilience: a warning from Turkana, Kenya.
Journal Article Lancet Planet Health · August 2025 Full text Link to item CiteRecent Grants
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028Synthesizing immunoinformatics and genetic epidemiology to identify signatures of natural functional immunity to malaria parasites
ResearchMentor · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028Real-world impact of next generation insecticidal nets for malaria control
ResearchPrincipal Investigator · Awarded by Moi University · 2024 - 2027View All Grants